Functional and Biochemical Evaluation of Platelet Aspirin Resistance After Coronary Artery Bypass Surgery

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Circulation

• Publication date

  2003-08-05

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.0000081770.51929.5APMID 12874188
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aspirin resistance

  2004cited by this paper
• Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular Events

  2002cited by this paper
• COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure, and expression

  2002cited by this paper
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

  2002cited by this paper
• Towards a definition of aspirin resistance: a typological approach

  2002cited by this paper
• Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets

  2002cited by this paper
• Flow cytometry analysis of platelet cyclooxygenase‐2 expression: induction of platelet cyclooxygenase‐2 in patients undergoing coronary artery bypass grafting

  2002cited by this paper
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

  2002cited by this paper
• The way I see it: House officers need formal career development

  2002cited by this paper
• Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events. Eikelboom JW, Hirsh J, Weitz J, Johnston M, Yi Q, Yusuf S. Circulation 2002; 105: 1650- 1655.

  2002cited by this paper
• Coagulation, fibrinolysis and platelet P-selectin expression in peripheral vascular disease.

  2001cited by this paper
• Profile and prevalence of aspirin resistance in patients with cardiovascular disease.

  2001cited by this paper
• Aspirin resistance after coronary artery bypass grafting.

  2001cited by this paper
• Recovery of platelet function after discontinuation of clopidogrel treatment in healthy volunteers.

  2001cited by this paper
• Molecular and Transcriptional Regulation of Megakaryocyte Differentiation

  2001cited by this paper
• Habitual smoking causes an abnormality in platelet thromboxane A2 metabolism and results in an altered susceptibility to aspirin effects.

  2000cited by this paper
• Diffusion of peroxynitrite into the human platelet inhibits cyclooxygenase via nitration of tyrosine residues.

  2000cited by this paper
• Cyclooxygenase-2 is essential for normal recovery from 5-fluorouracil-induced myelotoxicity in mice.

  1999cited by this paper
• Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis.

  1999cited by this paper
• Human cytokine responses to coronary artery bypass grafting with and without cardiopulmonary bypass.

  1999cited by this paper
• Cyclooxygenase-2 in human platelets as a possible factor in aspirin resistance.

  1999cited by this paper
• Kinetic basis for selective inhibition of cyclo-oxygenases.

  1999cited by this paper
• Lung epithelial damage at low concentrations of ambient ozone.

  1999cited by this paper
• Effects of terbogrel on platelet function and prostaglandin endoperoxide transfer.

  1998cited by this paper
• Cyclooxygenases 1 and 2.

  1998cited by this paper
• Variability in the Pharmacokinetics and Pharmacodynamics of Low Dose Aspirin in Healthy Male Volunteers

  1995cited by this paper
• Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients

  1994cited by this paper
• Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

  1994cited by this paper
• Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase.

  1993cited by this paper
• Blood-vessel wall arachidonate metabolism and its pharmacological modification in a new in vitro assay system

  1988cited by this paper
• Kinetics of aspirin absorption following oral administration of six aqueous solutions with different buffer capacities.

  1984cited by this paper

• Aspirin Responsiveness and Early Saphenous Vein Graft Occlusion After Coronary Artery Bypass Grafting: A CT Coronary Angiography Study.

  2026cites this paper
• Targeting MRP4 in drug resistance and aspirin treatment failure: implications for precision medicine.

  2026cites this paper
• Platelet Subpopulations in Health and Disease: Heterogeneity, Clinical Associations, and Therapeutic Targeting

  2025cites this paper
• Platelet drug response assay in patients undergoing off-pump coronary artery bypass grafting.

  2025cites this paper
• Efficacy and speed of effect after the first dose of aspirin in children with congenital heart disease

  2024cites this paper
• Clinical recurrence and antiplatelet drug resistance among patients with lower limb ischemia

  2024cites this paper
• Graft thrombosis after coronary artery bypass surgery and current practice for prevention

  2023cites this paper
• Aspirin

  2023cites this paper
• Safety outcomes of anti-platelet therapy post coronary artery bypass graft surgery: A systematic review and network meta-analysis of randomized control trials

  2023cites this paper
• Association of PeriOPerative Aspirin-ResisTance and CardioVascular Outcome (POPART- CVO) - a prospective non-interventional cohort study.

  2022cites this paper
• Assessment of platelet function and resistance to aspirin and clopidogrel in patients with peripheral arterial disease undergoing percutaneous transluminal angioplasty

  2021cites this paper
• Contemporary Clinical Use of Aspirin: Mechanisms of Action, Current Concepts, Unresolved Questions, and Future Perspectives

  2021cites this paper
• Dual Antiplatelet Therapy with Clopidogrel and Aspirin Versus Aspirin Monotherapy in Patients Undergoing Coronary Artery Bypass Graft Surgery

  2021cites this paper
• Role of Aspirin Resistance, Mechanical Factors and Inflammation on Early Saphenous Vein Graft Thrombosis After CABG

  2021cites this paper
• Once- versus Twice-Daily Aspirin in Patients at High Risk of Thrombotic Events: Systematic Review and Meta-Analysis

  2020cites this paper
• Prevalence rate of laboratory defined aspirin resistance in cardiovascular disease patients: A systematic review and meta-analysis

  2020cites this paper
• Progress on the Mechanism of Aspirin's Anti-tumor Effects.

  2020cites this paper
• Impact of Platelet Endothelial Aggregation Receptor-1 Genotypes on Platelet Reactivity and Early Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention and Treated With Aspirin and Clopidogrel.

  2019cites this paper
• Antiplatelet Therapy after Coronary Artery Bypass Graft Surgery, Inconsistency of Clinical Practice and Clinical Significance of Proven Resistance to Antiplatelet Agents

  2019cites this paper
• Aspirin Resistance: Cardiovascular Risk Game Changer.

  2019cites this paper
• Antiplatelet Resistance in Patients with Atherosclerosis

  2019cites this paper
• Role of Dipyrone in the High On-Treatment Platelet Reactivity amongst Acetylsalicylic Acid-Treated Patients Undergoing Peripheral Artery Revascularisation

  2018cites this paper
• Complex roles of the old drug aspirin in cancer chemoprevention and therapy

  2018cites this paper
• Effects of Ramadan fasting on aspirin resistance in type 2 diabetic patients

  2018cites this paper
• Urinary 11-Dehydro-Thromboxane B2 and Mortality in Patients With Stable Coronary Artery Disease.

  2017cites this paper
• Salicylic acid retention impairs aspirin reactivity in type 2 diabetes

  2017cites this paper
• Global Trends in Aspirin Resistance‐Related Research from 1990 to 2015: A Bibliometric Analysis

  2017cites this paper
• Aspirin Resistance in Subjects with Premature Coronary Artery Disease in Relation to Abdominal Fat and Adipocytokines

  2017cites this paper
• Flow cytometric analysis of platelet cyclooxygenase-1 and -2 and surface glycoproteins in patients with immune thrombocytopenia and healthy individuals

  2017cites this paper
• Monitoring of Antiplatelet Therapy

  2017cites this paper
• Platelets, diabetes and myocardial ischemia/reperfusion injury

  2017cites this paper
• Over-expression of cyclooxygenase-2 in increased reticulated platelets leads to aspirin resistance after elective off-pump coronary artery bypass surgery.

  2017cites this paper
• On‐pump Cardiac Surgery Enhances Platelet Renewal and Impairs Aspirin Pharmacodynamics: Effects of Improved Dosing Regimens

  2017influential citation
• Metamizole and Platelet Inhibition by Aspirin Following On-Pump Coronary Artery Bypass Grafting.

  2017cites this paper
• Platelet Prostanoids and their receptors

  2017cites this paper
• Maree , Fitzgerald : Aspirin and coronary artery disease Platelet aggregation and activation

  2017cites this paper
• Current controversies in the use of aspirin and ticagrelor for the treatment of thrombotic events

  2016cites this paper
• ASpirin and Plavix Following Coronary Artery Bypass Grafting ( ASAP - CABG ): A Randomized, Double - Blind, Placebo - Controlled Pilot Trial

  2016cites this paper
• Chronic Coronary Disease latelet Response to Low-Dose Enteric-Coated spirin in Patients With Stable Cardiovascular Disease

  2016cites this paper
• Aspirin dosing frequency in the primary and secondary prevention of cardiovascular events

  2016cites this paper
• Réponse à l'aspirine : différence de taux de thromboxane B2 sérique entre deux études cliniques

  2016cites this paper
• Prévalence et valeur pronostique de la résistance à l’aspirine chez les patients en ischémie critique chronique des membres inférieurs☆

  2016cites this paper
• Drug delivery and therapeutic impact of extended-release acetylsalicylic acid.

  2016cites this paper
• Extended-release acetylsalicylic acid for secondary prevention of stroke and cardiovascular events

  2016cites this paper
• [Prevalence and prognosis of aspirin resistance in critical limb ischemia patients].

  2016cites this paper
• Aspirin resistance in coronary heart disease: Current understandings and strategies

  2016cites this paper
• Atherothrombotic Risk Factors and Graft Disease

  2016cites this paper
• Antiplatelet drug resistance: Molecular insights and clinical implications.

  2015cites this paper
• Inhibition of Antiplatelet Effects of Aspirin by Nonopioid Analgesics

  2015cites this paper
• Personalized antiplatelet and anticoagulation therapy: applications and significance of pharmacogenomics

  2015cites this paper
• Incidence of Venous Thromboembolism and Benefits and Risks of Thromboprophylaxis After Cardiac Surgery: A Systematic Review and Meta‐Analysis

  2015cites this paper
• Acetylsalicylic acid resistance risk factors in patients with myocardial infarction

  2015cites this paper
• An Exploration of the Psychological Indicators of Aspirin Adherence, in Patients with Stable Coronary Artery Disease, using a Direct Assay Measurement.

  2015cites this paper
• Multiple daily doses of acetyl‐salicylic acid (ASA) overcome reduced platelet response to once‐daily ASA after coronary artery bypass graft surgery: a pilot randomized controlled trial

  2015cites this paper
• Drug-Free Platelets Can Act as Seeds for Aggregate Formation During Antiplatelet Therapy

  2015cites this paper
• HeartWare left ventricular assist device thrombosis in aspirin non-responder

  2014cites this paper
• Suboptimal Inhibition of Platelet Cyclooxygenase 1 by Aspirin in Systemic Lupus Erythematosus: Association With Metabolic Syndrome

  2014cites this paper
• Antiplatelet response to aspirin and clopidogrel in patients with coronary artery disease undergoing percutaneous coronary intervention

  2014cites this paper
• Updates on NSAIDs in patients with and without coronary artery disease: pitfalls, interactions and cardiovascular outcomes

  2014cites this paper
• Aspirin Resistance in Patients Undergoing Coronary Artery Bypass Grafting

  2014cites this paper
• Aspirin resistance in young men with Type 2 diabetes

  2014cites this paper
• High On-Treatment Platelet Reactivity in Peripheral Endovascular Procedures

  2014cites this paper
• Mechanisms of aspirin resistance.

  2014cites this paper
• Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome).

  2014cites this paper
• The use of platelet function testing in PCI and CABG patients.

  2014cites this paper
• Antiplatelet Therapy

  2013cites this paper
• Effect of acetylsalicylic acid usage and platelet transfusion on postoperative hemorrhage and activities of daily living in patients with acute intracerebral hemorrhage.

  2013cites this paper
• Assessment of platelet aspirin responsiveness in Turkish Population with PFA-100, serum thromboxane B 2 , soluble CD40 ligand and soluble P-Selectin)

  2013cites this paper
• Aspirin Therapy Resistance in Coronary Artery Bypass Grafting

  2013cites this paper
• KORONER ARTER HASTALIĞI YAYGINLIĞI VE TEKRARLAYAN PERKÜTAN KORONER GİRİŞİMLER ARASINDAKİ İLİŞKİ

  2013cites this paper
• Polymorphisms and high on-aspirin platelet reactivity after off-pump coronary artery bypass grafting

  2013cites this paper
• Alta atividade plaquetária residual em resposta ao ácido acetilsalicílico em pacientes com síndrome isquêmica miocárdica instável sem supradesnível de ST: comparação entre as fases aguda e tardia

  2013cites this paper
• Drug/drug interaction of common NSAIDs with antiplatelet effect of aspirin in human platelets.

  2013cites this paper
• Pharmacology of Antiplatelet Agents

  2013cites this paper
• Antiplatelet drug resistance and variability in response: the role of antiplatelet therapy monitoring.

  2013cites this paper
• Complexes of pectin polysaccharide with acetylsalicylic acid

  2013cites this paper
• Valdecoxib: the rise and fall of a COX-2 inhibitor

  2013cites this paper
• Effectiveness of antiplatelet therapy in atherosclerotic disease: comparing the ASA low-response prevalence in CVD, CAD and PAD

  2013cites this paper
• Controversies in cardiovascular medicine Low-dose aspirin in primary prevention : cardioprotection , chemoprevention , both , or neither ?

  2013cites this paper
• Resistance to antiplatelet treatment: The clinical relevance of platelet function assays

  2012cites this paper
• Antiplatelet effect of aspirin in patients with coronary artery disease.

  2012cites this paper
• Microembolic signals and aspirin resistance in patients with carotid stenosis.

  2012cites this paper
• Thrombosis and Aspirin: Clinical Aspect, Aspirin in Cardiology, Aspirin in Neurology, and Pharmacology of Aspirin

  2012cites this paper
• Aldose Reductase, Oxidative Stress, and Diabetic Mellitus

  2012cites this paper
• Cerebral Microembolization After Bioprosthetic Aortic Valve Replacement: Comparison of Warfarin Plus Aspirin Versus Aspirin Only

  2012cites this paper
• Aspirin Prophylaxis for the Prevention of Thrombosis: Expectations and Limitations

  2012cites this paper
• Evaluation of aspirin's effect on platelet function early after coronary artery bypass grafting.

  2012cites this paper
• Aspirin Resistance: Clinical Significance

  2012cites this paper
• Postoperative non-steroidal anti-inflammatory drugs and colorectal anastomotic leakage

  2012cites this paper
• Acetyl salicylic acid resistance in patients with chronic stable angina and the correlation with coronary risk factors.

  2012cites this paper
• High on treatment platelet reactivity against aspirin by non-steroidal anti-inflammatory drugs – pharmacological mechanisms and clinical relevance

  2012cites this paper
• Postoperative non-steroidal anti-inflammatory drugs and colorectal anastomotic leakage. NSAIDs and anastomotic leakage.

  2012cites this paper
• Advances in monitoring of aspirin therapy

  2012cites this paper
• Coronary artery bypass graft surgery up‐regulates genes involved in platelet aggregation

  2012cites this paper
• Relación entre el efecto antiagregante de la aspirina y el recuento plaquetario. Posibles implicaciones en la dosificación The Association of Antiplatelet Aggregation Effect of Aspirin and Platelet Count. Possible Dosage Implications

  2012cites this paper
• ASPIRIN RESISTANCE AMONG PATIENTS WITH STABLE ISCHEMIC HEART DISEASE ASSESSED BY MEASUREMENT OF 11-DEHYDROTHROMBOXANE B2 IN URINE

  2012cites this paper
• Aspirin response variability after major orthopedic surgery.

  2012cites this paper
• Aspirin resistance: effect of clinical, biochemical and genetic factors.

  2011cites this paper
• Aspirin extrusion from human platelets through multidrug resistance protein-4-mediated transport: evidence of a reduced drug action in patients after coronary artery bypass grafting.

  2011cites this paper
• Functional evaluation of platelet aspirin resistance after on-pump coronary bypass grafting using multiple aggregation tests.

  2011cites this paper